Sramana Mitra: Give me some examples of the kind of medical companies that you have invested in. Alain le Loux: I’ve invested in two companies. They are doing great, but it takes a lot of time. For one of them, we are already eight years in. Sramana Mitra: What do they do?
Sramana Mitra: What differences are you seeing in the trends in Europe versus America? Alain le Loux: For follow-on rounds in the US, the money is easier than in Europe. In Europe, only less than 10% of Series A investments raise a B round. That’s a pity. It looks like there is more money available
Sramana Mitra: We actually work only with IT and IT-enabled companies. We don’t do energy. We don’t do biotech. We don’t do cleantech. Where we overlap is in the robotics area mostly. If you have stuff going on in healthcare IT or bioinformatics, that would be of interest to us. It sounds like robotics is
Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Alain le Loux was recorded on July 2019. Alain le Loux is General Partner at Cottonwood Technology Fund. The firm invests in hardcore technology startups in Northern Europe and the Southwest of